{
    "clinical_study": {
        "@rank": "25321", 
        "brief_summary": {
            "textblock": "To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy\n      accessible cancer who have failed previous therapy or to whom no standard therapies are\n      available.  To determine the pharmacokinetic profile of S-3304 in this patient population"
        }, 
        "brief_title": "A Phase 1 Study of S-3304 in Patients With Solid Tumors", 
        "completion_date": "October 2003", 
        "condition": "Solid Tumors", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)\n\n          -  Must be able to tolerate oral medication Exclusion criteria\n\n          -  Patients with other serious illnesses\n\n          -  Patients who are receiving treatments"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "28", 
        "firstreceived_date": "April 9, 2002", 
        "id_info": {
            "nct_id": "NCT00033215", 
            "org_study_id": "0110P1416"
        }, 
        "intervention": {
            "intervention_name": "S-3304", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "neovascularization", 
            "matrix metalloproteinases", 
            "antiangiogenesis", 
            "type IV collagenases"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80262"
                    }, 
                    "name": "University of Colorado Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush-Presbyterian-St. Lukes Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14263"
                    }, 
                    "name": "Roswell Park Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Foundation"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase 1 Study of S-3304 in Patients With Solid Tumors", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00033215"
        }, 
        "source": "Shionogi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shionogi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2003"
    }, 
    "geocoordinates": {
        "Cleveland Clinic Foundation": "41.499 -81.695", 
        "Roswell Park Cancer Center": "42.886 -78.878", 
        "Rush-Presbyterian-St. Lukes Medical Center": "41.878 -87.63", 
        "University of Colorado Hospital": "39.739 -104.985"
    }
}